8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (Nov 2, 2023)

Filed November 2, 2023For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) has filed an 8-K on November 2, 2023, to report its financial results for the third quarter ended September 30, 2023. While the filing itself does not contain the detailed financial figures, it references a furnished press release (Exhibit 99.1) that provides this information. Investors should refer to this press release for specifics on revenue, profitability, and other key financial metrics. This announcement is crucial for understanding the company's recent performance and its trajectory moving forward. The key takeaway for investors is that Alnylam is providing an update on its financial condition and operational results for the most recent quarter. The 8-K serves as the official notification of this release, directing stakeholders to the accompanying press release for the comprehensive data. It's important to note that the information furnished in this 8-K, including the press release, is not considered "filed" for certain regulatory purposes, which is standard practice for such announcements.

Key Highlights

  • 1Alnylam Pharmaceuticals, Inc. (ALNY) announced Q3 2023 financial results via an 8-K filing on November 2, 2023.
  • 2The detailed financial results are presented in a press release furnished as Exhibit 99.1 to the 8-K.
  • 3Investors need to consult Exhibit 99.1 for specific financial performance data for the quarter ended September 30, 2023.
  • 4The filing confirms that the press release contains information on the company's operations and financial condition.
  • 5The information provided is furnished, not filed, meaning it has specific implications under the Securities Exchange Act.
  • 6This 8-K serves as the official notification vehicle for the company's quarterly financial update.

Frequently Asked Questions

The specific financial results for the quarter ended September 30, 2023, are detailed in the press release furnished as Exhibit 99.1 to this Form 8-K filing.

When information is 'furnished' under Item 2.02 of an 8-K, it means the company is providing the update, but it is not subject to the same level of liability under Section 18 of the Exchange Act as if it were 'filed'. It also won't be automatically incorporated into other SEC filings unless specifically referenced.

No, this 8-K filing itself primarily serves as notification of the results and directs investors to the accompanying press release (Exhibit 99.1) for the detailed financial data, including revenue and earnings.